Author

Xizhong Xu

Institutions: Shandong Transportation Research Institute, Wuxi Fourth People's Hospital

Observed institutions: Shandong Transportation Research Institute, Wuxi Fourth People's Hospital, Ministry of Transport

ORCID: 0000-0003-0777-006X

Observed ORCID: 0000-0003-0777-006X

OpenAlex ID: A5047474726

Technical development and long-term performance observations of long-life asphalt pavement: A case study of Shandong Province

2022 · Lin Wang, Jincheng Wei, et al. · Journal of Road Engineering · 36

PDF

Study on the Optimum Steel Slag Content of SMA-13 Asphalt Mixes Based on Road Performance

2021 · Wei Chen, Jincheng Wei, et al. · Coatings · 24

PDF

Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China

2023 · Minmin Zhao, Shanhu Qiu, et al. · Targeted Oncology · 21

PDF

Effect of Waterborne Polyurethane on Rheological Properties of Styrene-Butadiene Rubber Emulsified Asphalt

2022 · Yan Li, Guojing Huang, et al. · Journal of Materials in Civil Engineering · 21

Research on the Road Performance of Asphalt Mixtures Based on Infrared Thermography

2022 · Wei Chen, Kesen Wei, et al. · Materials · 21

PDF

Research on the Quality of Asphalt Pavement Construction Based on Nondestructive Testing Technology

2022 · Wei Chen, Guiling Hu, et al. · Coatings · 14

PDF

Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study

2023 · Xinyi Hong, Shanhu Qiu, et al. · Drug Design Development and Therapy · 11

PDF

Rare Vulvar Angiomyofibroblastoma: Case Series and Literature Review

2023 · Ling Chen, Qiuwei Sun, et al. · International Journal of Women s Health · 9

PDF

A nomogram of preoperative indicators predicting lymph vascular space invasion in cervical cancer

2024 · Qu Guo, Yufeng Gao, et al. · Archives of Gynecology and Obstetrics · 6

SHR-A1811 in patients (pts) with HER2-expressing advanced gynecological cancers (Gynecol C): A phase 2 study.

2025 · Beihua Kong, Jie Jiang, et al. · Journal of Clinical Oncology · 5

PDF

Characterizing Asphalt Binder Phase Transitions via Dynamic Mechanical Analysis: Performance Implications and SARA Fraction Correlations

2025 · Yanzhu Wang, Jincheng Wei, et al. · Coatings · 4

PDF

Mechanical characteristics research of new asphalt pavement structure based on geogrid

2021 · Guangcong Ni, Xiaomeng Zhang, et al. · E3S Web of Conferences · 3

PDF

SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study

2025 · Jianqing Zhu, Guangyi Jiang, et al. · International Journal of Gynecological Cancer · 2

SHR ‐2004, a Humanized Monoclonal Antibody Targeting Factor XI , for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active‐Controlled Phase 2 Study

2026 · Guangyi Jiang, Jie Tang, et al. · American Journal of Hematology · 1

PDF

Crack Extension Characteristics of Continuously Reinforced Concrete and Asphalt Composite Pavements Under Thermo-Mechanical Coupling and Non-Uniform Tire Loading

2026 · Xizhong Xu, Xiaomeng Zhang, et al. · Coatings · 1

Prognostic Nutritional Index and Postoperative Outcomes in Patients with Ovarian Cancer after Abdominal Surgery

2025 · Shizhang Yang, Jinjin Yu, et al. · Indian Journal of Gynecologic Oncology · 1

Optimization of Pavement Structure Using High-Modulus Asphalt Coating Considering the Effects of Base-Course Combinations

2024 · Hao Wang, Jincheng Wei, et al. · Coatings · 1

Asphalt Pavement Design and Durability Under CMIP6 Warming in China

2026 · Feifei Fan, Xizhong Xu, et al. · Coatings

Comparative Low-Temperature Flexural and Creep Responses of Two SBS-Based Asphalt Mixture Formulations

2026 · Shiquan Liu, Jincheng Wei, et al. · Coatings

Mechanical Response and Fatigue Life Analysis of Full Depth Asphalt Pavement Structure

2023 · Bensheng Lu, Xizhong Xu, et al. · Advances in transdisciplinary engineering

PDF

Real-world data from a multi-center study: Insights to the efficacy and safety in patients with ovarian cancer (OC) received niraparib as first-line (1st-L) maintenance therapy (MT).

2023 · Minmin Zhao, Yang Shen, et al. · Journal of Clinical Oncology

Efficacy and safety of anlotinib in overall and disease-specific advanced gynecological cancer: A real-world study.

2023 · Xinyi Hong, Shanhu Qiu, et al. · Journal of Clinical Oncology

PDF

Works count: 22

Citation count: 181

H-index: 8

I10-index: 7